Longitudinal association between pain severity and subsequent opioid use in prescription opioid dependent patients with chronic pain

Drug and Alcohol Dependence

Volumn 163, Issue , 2016, Pages 216-221

  Griffin, Margaret L ^a,b   McDermott, Katherine A ^a   McHugh, R Kathryn ^a,b   Fitzmaurice, Garrett M ^a,c   Jamison, Robert N ^d   Weiss, Roger D ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Addiction; Opioid use disorder; Outcome; Pain; Prescription opioids; Treatment

Indexed keywords

BUPRENORPHINE PLUS NALOXONE; NARCOTIC ANALGESIC AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BECK DEPRESSION INVENTORY; BIPOLAR DISORDER; CHRONIC PAIN; DISEASE ASSOCIATION; DISEASE DURATION; DRUG USE; EDUCATIONAL STATUS; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY (TOPIC); OPIATE ADDICTION; PAIN SEVERITY; PATIENT COUNSELING; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RELAPSE; TREATMENT DURATION; TREATMENT WITHDRAWAL; ADOLESCENT; ANALGESIA; CONTROLLED STUDY; COUNSELING; DRUG MISUSE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; BUPRENORPHINE, NALOXONE DRUG COMBINATION; CHRONIC PAIN; COUNSELING; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PAIN MANAGEMENT; PRESCRIPTION DRUG MISUSE; RECURRENCE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84965029121     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2016.04.023     Document Type: Article

References (35)

1. Apkarian A.V., Sosa Y., Krauss B.R., Thomas P.S., Fredrickson B.E., Levy R.E., Harden R.N., Chialvo D.R. Chronic pain patients are impaired on an emotional decision-making task. Pain 2004, 108:129-136.
2. Barry D.T., Beitel M., Garnet B., Joshi D., Rosenblum A., Schottenfeld R.S. Relations among psychopathology, substance use, and physical pain experiences in methadone-maintained patients. J. Clin. Psychiatry 2009, 70:1213-1218.
3. Beck A.T., Steer R.A., Brown G.K. Manual for the Beck Depression Inventory-II 1996, Psychological Corporation, San Antonio, TX.
4. Chakrabarti A., Woody G.E., Griffin M.L., Subramaniam G., Weiss R.D. Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study. Drug Alcohol Depend. 2010, 107:253-256.
5. Cicero T.J., Lynskey M., Todorov A., Inciardi J.A., Surratt H.L. Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse. Pain 2008, 139:127-135.
6. Cleeland C.S., Ryan K.M. Pain assessment: global use of the Brief Pain Inventory. Ann. Acad. Med. Singapore 1994, 23:129-138.
7. Dhingra L., Masson C., Perlman D.C., Seewald R.M., Katz J., McKnight C., Homel P., Wald E., Jordan A.E., Young C., Portenoy R.K. Epidemiology of pain among outpatients in methadone maintenance treatment programs. Drug Alcohol Depend. 2013, 128:161-165.
8. Dhingra L., Perlman D.C., Masson C., Chen J., McKnight C., Jordan A.E., Wasser T., Portenoy R.K., Cheatle M.D. Longitudinal analysis of pain and illicit drug use behaviors in outpatients on methadone maintenance. Drug Alcohol Depend. 2015, 149:285-289.
9. Dreifuss J.A., Griffin M.L., Frost K., Fitzmaurice G.M., Potter J.S., Fiellin D.A., Selzer J., Hatch-Maillette M., Sonne S.C., Weiss R.D. Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: results from a multisite study. Drug Alcohol Depend. 2013, 131:112-118.
10. Fiellen, D.A., Pantalon, M.V., Schottenfeld, R.S., Gordon, L., O'Connor, P.G., 1999. Standard Medication Management for Bup/Nx Treatment of Opioid Analgesic Dependence for Use in NIDA CTN-0030. Based on Manual for Standard Medical Management of Opioid Dependence with Buprenorphine. Unpublished Manual, Yale University.
11. Fox A.D., Sohler N.L., Starrels J.L., Ning Y., Giovanniello A., Cunningham C.O. Pain is not associated with worse office-based buprenorphine treatment outcomes. Subst. Abuse 2012, 33:361-365.
12. Green T.C., Grimes Serrano J.M., Licari A., Budman S.H., Butler S.F. Women who abuse prescription opioids: findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database. Drug Alcohol Depend. 2009, 103:65-73.
13. Ilgen M.A., Trafton J.A., Humphreys K. Response to methadone maintenance treatment of opiate dependent patients with and without significant pain. Drug Alcohol Depend. 2006, 82:187-193.
14. Jamison R.N. Learning to Master Your Chronic Pain 1996, Professional Resource Press, Sarasota, FL.
15. Jamison R.N., Kauffman J., Katz N.P. Characteristics of methadone maintenance patients with chronic pain. J. Pain Symptom Manage. 2000, 19:53-62.
16. Jensen M.P., Smith D.G., Ehde D.M., Robinsin L.R. Pain site and the effects of amputation pain: further clarification of the meaning of mild, moderate, and severe pain. Pain 2001, 91:317-322.
17. Keller S., Bann C.M., Dodd S.L., Schein J., Mendoza T.R., Cleeland C.S. Validity of the Brief Pain Inventory for use in documenting the outcomes of patients with noncancer pain. Clin. J. Pain 2004, 20:309-318.
18. Martin T.J., Ewan E. Chronic pain alters drug self-administration: implications for addiction and pain mechanisms. Exp. Clin. Psychopharmacol. 2008, 16:357-366.
19. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. International Association for the Study of Pain, Task Force on Taxonomy 1994, IASP Press, Seattle. H. Merskey, N. Bogduk (Eds.).
20. Neumann A.M., Blondell R.D., Jaanimagi U., Giambrone A.K., Homish G.G., Lozano J.R., Kowalik U., Azadfard M. A preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction. J. Addict. Dis. 2013, 32:68-78.
21. Pantalon, M.V., Fiellen, D.A., Schottenfeld, R.S., Gordon, L., O'Connor, P.G., 1999. Manual for Individual Drug Counseling for Opioid Dependent Patients Receiving Buprenorphine. Based on Manual for Enhanced Medical Management of Opioid Dependence with Buprenorphine. Unpublished Manual, Yale University.
22. Peles E., Schreiber S., Adelson M. Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients. Drug Alcohol Depend. 2006, 82:103-110.
23. Potter J.S., Dreifuss J.A., Marino E.N., Provost S.E., Dodd D.R., Rice L.S., Fitzmaurice G.M., Griffin M.L., Weiss R.D. The multi-site prescription opioid addiction treatment study: 18-month outcomes. J. Subst. Abuse Treat. 2015, 48:62-69.
24. Potter J.S., Prather K., Weiss R.D. Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities. Am. J. Addict. 2008, 17:121-125.
25. Robins L.N., Wing J., Wittchen H.U., Helzer J.E., Babor T.F., Burke J., Farmer A., Jablenski A., Pickens R., Regier D.A., et al. The Composite International Diagnostic Interview: an epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch. Gen. Psychiatry 1988, 45:1069-1077.
26. Rosenblum A., Parrino M., Schnoll S.H., Fong C., Maxwell C., Cleland C.M., Magura S., Haddox J.D. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend. 2007, 90:64-71.
27. Serlin R.C., Mendoza T.R., Nakamura Y., Edwards K.R., Cleeland C.S. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995, 61:277-284.
28. Sobell L.C., Sobell M.B. Timeline follow-back: a technique for assessing self-reported alcohol consumption. Measuring Alcohol Consumption: Psychosocial And Biochemical Methods 1992, 41-72. Humana Press, Totowa, NJ. R.Z. Litten, J.P. Allen (Eds.).
29. Tan G., Jensen M.P., Thornby J.I., Shanti B.F. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J. Pain 2004, 5:133-137.
30. Trafton J.A., Oliva E.M., Horst D.A., Minkel J.D., Humphreys K. Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. Drug Alcohol Depend. 2004, 73:23-31.
31. Verdejo-Garcia A., Lopez-Torrecillas F., Calandre E.P., Delgado-Rodriguez A., Bechara A. Executive function and decision-making in women with fibromyalgia. Arch. Clin. Neuropsychol. 2009, 24:113-122.
32. Wasan A.D., Butler S.F., Budman S.H., Fernandez K., Weiss R.D., Greenfield S.F., Jamison R.N. Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients?. Clin. J. Pain 2009, 25:193-198.
33. Weiss R.D., Potter J.S., Copersino M.L., Prather K., Jacobs P., Provost S., Chim D., Selzer J., Ling W. Conducting clinical research with prescription opioid dependence: defining the population. Am. J. Addict. 2010, 19:141-146.
34. Weiss R.D., Potter J.S., Fiellin D.A., Byrne M., Connery H.S., Dickinson W., Gardin J., Griffin M.L., Gourevitch M.N., Haller D.L., Hasson A.L., Huang Z., Jacobs P., Kosinski A.S., Lindblad R., McCance-Katz E.F., Provost S.E., Selzer J., Somoza E.C., Sonne S.C., Ling W. Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch. Gen. Psychiatry 2011, 68:1238-1246.
35. Weiss R.D., Potter J.S., Provost S.E., Huang Z., Jacobs P., Hasson A., Lindblad R., Connery H.S., Prather K., Ling W. A multi-site, two-phase, prescription opioid addiction treatment study (POATS): rationale, design, and methodology. Contemp. Clin. Trials 2010, 31:189-199.